[An update on limitations of intravenous thrombolysis to treat acute ischemic stroke.]

[An update on limitations of intravenous thrombolysis to treat acute ischemic stroke.]
Presse Med. 2015 Feb 16;
Authors: Masingue M, Alamowitch S
Abstract
The benefit of intravenous thrombolysis with rt-pa has been demonstrated in acute ischemic stroke up to 4h30 after the first symptoms. The number of patients with stroke treated by rt-pa remains low at less than 5%. In the license of rt-pa in acute ischemic stroke, there are numerous contra-indications explained by the fear of cerebral hemorrhagic complications. These contra-indications are based on the first therapeutic trials published more than 15 years ago, but are not all evidence-based. Large post-marketing registers and new randomized trials have shown a favorable ratio benefit/risk of rt-pa in acute ischemic strokes in some classical contra-indications. Reconsidering some of the official contra-indications would increase the target population with treatable acute ischemic stroke using rt-pa to 20%.
PMID: 25697630 [PubMed - as supplied by publisher]

Source: Presse Medicale - February 16, 2015 Category: Journals (General) Authors: Masingue M, Alamowitch S Tags: Presse Med Source Type: research